GEODIS opens Manchester pharma hub to expand temperature controlled capacity

Estimated reading time: 4 minutes

GEODIS has officially opened a new temperature controlled pharmaceutical and healthcare logistics facility in Manchester, adding 2,000 pallet positions to its operations serving customers across the United Kingdom and Ireland.

The warehouse, which became operational on June 1, supports inventory management, short term storage, returns handling and cross docking for medicines and other healthcare products requiring controlled conditions. Global GEODIS representatives, UK and Ireland employees and business partners attended the formal opening ceremony.

Located near Manchester Airport and the M6 and M62 motorway corridors, the facility combines access to international air cargo services with road distribution links across Britain. The location is about five miles from the airport, according to information published by the Greater Manchester Chamber of Commerce.

The warehouse provides controlled room temperature storage maintained between 15°C and 25°C, alongside chilled areas operating between 2°C and 8°C. Frozen storage can be added if customer demand requires it.

For pharmaceutical shippers, these temperature ranges are more than warehouse settings. A small and unnoticed temperature deviation can affect the condition, regulatory status or commercial value of an entire shipment. The facility therefore uses continuous temperature monitoring supported by alert systems operating around the clock.

Dedicated returns areas have also been included. Returned medicines cannot generally be handled like ordinary retail products. They may require quarantine, inspection, confirmation of their temperature history and a documented decision on whether they can re-enter inventory.

The warehouse is compliant with Good Distribution Practice requirements and holds Wholesale Distribution Authorisation pharmaceutical compliance. GEODIS said the site also meets ISO 9001, ISO 14001, ISO 45001 and ISO 50001 standards, together with TAPA, Authorised Economic Operator and dangerous goods requirements.

Operations are supported by a validated warehouse management system designed to provide barcode scanning, batch traceability, audit trails and real time inventory visibility.

Such controls are particularly important when a shipment must be traced by production batch, storage location or handling history. In a conventional warehouse, a missing scan may cause an inventory discrepancy. In pharmaceutical logistics, the same gap can become a compliance issue that delays distribution.

The site will handle both inventory holding and faster moving cross docking flows. Cross docking allows cargo arriving from one transport service to be prepared for onward movement with limited storage time, which can reduce handling and shorten the period that sensitive products remain inside the distribution network.

“ This new facility allows us to provide highly reliable end to end solution for temperature sensitive healthcare products,” said Paul Morris, head of the pharma and healthcare vertical for GEODIS in the UK.

Morris said the monitoring systems, compliance standards and transport connections would support pharmaceutical and biotechnology companies seeking safe and scalable logistics services.

The Manchester location provides an alternative to pharmaceutical logistics networks centred heavily on southern England. Its motorway access supports distribution towards the Midlands, Scotland, Wales and southern regions, while Manchester Airport connects the warehouse with international airfreight services.

The facility is also positioned near a regional life sciences and healthcare market. For cargo owners, the practical value lies in placing controlled storage close to both an international gateway and inland distribution routes.

This can be compared with adding another controlled valve to a supply chain. When airport congestion, road disruption or sudden demand affects one route, regional capacity gives shippers another location through which inventory can be received, stored or redirected.

The warehouse has been designed to support GEODIS customers’ sustainability targets through supply chain optimisation. Measures installed at the site include energy efficient refrigeration, LED lighting and waste reduction initiatives.

The company did not disclose the investment value, expected annual cargo throughput or the number of employees based at the facility.

Its opening extends GEODIS’ specialist pharmaceutical infrastructure at a time when healthcare supply chains are placing greater emphasis on temperature monitoring, documented handling, inventory visibility and reliable connections between airfreight gateways and domestic distribution networks.